Exploring new mechanisms in cancer molecular pathways and pathogenic cell transformation: PIP4K2A as a prognostic marker and therapeutic target in cutaneous malignant melanoma

Wen-fei Luo, Ding-ming Song, Tong Shen, Yi-bo He, Hong-yang Du, Ming-jue Si, Lu-Wei Fang · 2024

Read Exploring new mechanisms in cancer molecular pathways and pathogenic cell transformation: PIP4K2A as a prognostic marker and therapeutic target in cutaneous malignant melanoma by Wen-fei Luo, Ding-ming Song, Tong Shen, Yi-bo He, Hong-yang Du, Ming-jue Si, Lu-Wei Fang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11585527.txt.

Description

Melanoma of the skin is fierce and spreads early, and a gene called PIP4K2A may help drive it. Wen-fei Luo and co-authors investigated that gene in 2024, using single-cell sequencing of patient samples plus machine learning models. They focused on how the gene interacts with T cells, the immune cells that checkpoint drugs unleash against tumors.

The gene ran high in melanoma and tracked with worse stage and poorer outlook. Tumors with high levels answered immune therapy less well, and the gene counted as a risk factor for drug response. Lab staining of tissue confirmed the pattern. The authors present the gene as a marker for prognosis and a possible target, and as a clue to how T cells behave inside these tumors.

Catalog record

CREATORWen-fei Luo, Ding-ming Song, Tong Shen, Yi-bo He, Hong-yang Du, Ming-jue Si, Lu-Wei Fang
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11585527

Browse the full library · About the Tower of Babel